CClinicalTrials.gg
Status unknownNCT05449938Updated Jul 8, 2022

Periodontal Phenotype and Scaling and Root Planing

An interventional study of Scaling and root planing in Periodontitis, sponsored by Postgraduate Institute of Dental Sciences Rohtak. Status unknown at 1 site in India. Open to participants aged 35 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-07-08.

Sponsored by Postgraduate Institute of Dental Sciences Rohtak · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jul 2022), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Sep 2021, registered Jun 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Non-randomized
Ages
35 Years to 55 Years
Sex
All
01

Study summary

Periodontal phenotype has been recognized as one of the key factors that may potentially impact the outcome of a variety of periodontal surgical and non-surgical procedures. Taking into consideration the inconsistent findings of the studies done in this regard,outcomes of scaling and root planing with respect to periodontal phenotype.

With this aim, the present study would be conducted to assess the influence of periodontal phenotype on outcome of scaling and root planing in periodontitis patients.

Read the detailed description

AIM: To evaluate the influence of periodontal phenotype on the outcomes of scaling and root planing in periodontitis patients.

OBJECTIVES:

To assess the improvement in pocket probing depth (PPD), clinical attachment level (CAL), bleeding in pocket probing (BOPP), bleeding on marginal probing (BOMP), gingival marginal position (GMP), gingival recession (GR), plaque index (PI), and gingival index (GI) after scaling and root planing (SRP) in periodontitis patients with thin or thick periodontal phenotype.

SETTING: Department of periodontics and oral implantology, PGIDS, Rohtak, Haryana.

STUDY DESIGN: Comparative Interventional study.

TIME FRAME: 12 months (september 2021- August 2022)

POPULATION:

Systemically healthy patients with periodontitis (periodontitis stage II and stage III) and thin/thick periodontal phenotype in maxillary and mandibular incisors will be included.

02

Conditions studied

  • Periodontitis

Browse trials for

03

In context

Periodontitis

1,635 studies on the registry are indexed under Periodontitis; 327 are open to participants now.

This study's planned enrollment of 60 is above the median of 45 across 1,191 interventional studies indexed under Periodontitis.

Browse Periodontitis studies →

Lead sponsor

Postgraduate Institute of Dental Sciences Rohtak is the lead sponsor of 209 studies on the registry; 71 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
35 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Systemically healthy patients with periodontitis (periodontitis stage 2 and stage 3) and thin/thick periodontal phenotype in maxillary and mandibular incisors will be included.

Exclusion criteria

Exclusion Criteria:

  • Systemic condition known to affect the course of periodontal disease like diabetes mellitus or immunogenic disorders.
  • Patient on anti-inflammatory drugs or antibiotics or history of treatment with medication known to influence periodontal status or healing within last 2 years.
  • Current or former smoker or use of tobacco in any form
  • History of periodontal treatment in last 2 years
  • Crowding in anterior teeth.
  • Pregnant or lactating females.
  • Individuals with restorations on anterior teeth.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Thick periodontal phenotype

    Stage II and stage III periodontitis Patient with thick periodontal phenotype will be enrolled using probe transparency method .

    Procedure: Scaling and root planing

  • Active comparator
    Thin periodontal phenotype

    Stage II and stage III periodontitis Patient with thin periodontal phenotype will be enrolled using probe transparency method.

    Procedure: Scaling and root planing

Interventions

  • ProcedureScaling and root planing

    Scaling and root planing involves removal of plaque and calculus on tooth surface.

06

What researchers measure

Primary outcomes

  1. Probing pocket depth

    Change in pocket probing depth from baseline to 6 months

    Time frame: 6 months

  2. BLEEDING ON POCKET PROBING (BOPP)

    Change in bleeding on pocket probing depth from baseline to 6 months

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
  • Post Graduate Institute Of Dental Science
    Rohtak, Haryana 124001, India
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 8, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05449938
Lead sponsor
Postgraduate Institute of Dental Sciences Rohtak
Responsible party
Sponsor
First posted
Jul 8, 2022
Start date
Sep 1, 2021
Primary completion
Jul 2022 (estimated)
Completion
Aug 2022 (estimated)
Last update
Jul 8, 2022

Study contacts

Rajinder Kr Sharma, MDS
Contact
rksharmamds@yahoo.in
9416358222
Krishan Kant, BDS
principal investigator · POST GRADUATE INSTITUTE OF DENTAL SCIENCES ROHTAK

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion